Do Disasters Delay Early Cancer Diagnoses?
Natural disasters and the COVID-19 pandemic disrupted colorectal cancer diagnoses in Puerto Rico, leading to a rise in delayed diagnoses.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Breakthroughs in Diagnosing Colorectal Cancer with Rare Genetic Variants
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Colorectal
Latest
New Industry Collaboration Seeks to Advance Colorectal Cancer Screening
The new collaboration aims to enhance colorectal cancer (CRC) screening using advanced diagnostic platforms and novel biomarkers.
FDA Approves Geneoscopy’s Multi-Target Stool RNA Colorectal Cancer Test
Geneoscopy received U.S. FDA approval for ColoSense, a noninvasive colorectal cancer screening test that uses RNA biomarkers.
Read More
Researchers Identify the Critical Gap in Colorectal Cancer Screening
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
Read More
How Effective are Blood Tests for Colorectal Cancer Screening?
New studies are cautioning against the use of blood tests to replace established colorectal cancer screening tests.
Read More
Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Read More
Blood Test Shows High Accuracy for Colorectal Cancer Detection
The blood test is intended for screening colorectal cancer in people who are of average risk and not experiencing symptoms.
Read More
Preventive Blood Test for Colorectal Cancer Gets FDA Breakthrough Device Designation
The PreveCol test for cancer is aimed at the early detection of biomarkers in blood associated with colorectal neoplasia.
Read More
Guardant Gives Tentative Date of FDA Advisory Panel Review for Shield Blood Test
Guardant Health announced the FDA is scheduled to review the premarket approval application for the company’s colorectal cancer blood test.
Read More
How At-Home Colorectal Cancer Screenings Pose Challenges
Researchers found that about 10% of at-home screening tests for colorectal cancer tests could not be processed, mostly due to patient error.
Read More
DiaCarta Launches OTC at Home Fecal Occult Blood Test
DiaCarta has received US FDA 510(k) clearance for its over the counter (OTC) at home iColon Fecal Occult Blood Test (FOBT).
Read More
Universal DX Collaborates with Quest on Advanced Colorectal Cancer Blood Tests
Universal DX announced a strategic collaboration with Quest Diagnostics designed to improve colorectal cancer screening in the United States.
Read More
Strategic Collaboration Aims to Bring Advanced Colorectal Cancer Screening to U.S.
Universal DX has announced a strategic collaboration with Quest Diagnostics to improve colorectal cancer screening in the United States.
Read More
Geneoscopy and Labcorp Partner to Distribute Noninvasive Colorectal Cancer Test
Geneoscopy’s multi-target stool RNA (mt-sRNA) biomarker panel is designed to detect precancerous lesions and colorectal cancer.
Read More
AI Tool Outperforms Other Colorectal Cancer Analysis Methods
Researchers have developed an artificial intelligence (AI) tool for automatic colorectal cancer tissue analysis.Â
Read More
Liquid Biopsy May Guide Colon Cancer Adjuvant TreatmentÂ
Liquid biopsy may be used to improve the response to standard chemotherapy regimens in patients with stage III or stage II colon cancer.
Read More
Colorectal Cancer: A New At-Home Test Increases Diagnostic Accuracy
The ColoAlert test is designed as a complement to colonoscopies and is designed to help detect colorectal cancer early.
Read More